Cargando…
Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species
Mammalian mesenchymal stem cells (MSCs) have been shown to be strongly immunosuppressive in both animal disease models and human clinical trials. We have reported that the key molecule mediating immunosuppression by MSCs is species dependent: indoleamine 2,3-dioxygenase (IDO) in human and inducible...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921585/ https://www.ncbi.nlm.nih.gov/pubmed/24162664 http://dx.doi.org/10.1038/cdd.2013.149 |
_version_ | 1782303316089241600 |
---|---|
author | Su, J Chen, X Huang, Y Li, W Li, J Cao, K Cao, G Zhang, L Li, F Roberts, A I Kang, H Yu, P Ren, G Ji, W Wang, Y Shi, Y |
author_facet | Su, J Chen, X Huang, Y Li, W Li, J Cao, K Cao, G Zhang, L Li, F Roberts, A I Kang, H Yu, P Ren, G Ji, W Wang, Y Shi, Y |
author_sort | Su, J |
collection | PubMed |
description | Mammalian mesenchymal stem cells (MSCs) have been shown to be strongly immunosuppressive in both animal disease models and human clinical trials. We have reported that the key molecule mediating immunosuppression by MSCs is species dependent: indoleamine 2,3-dioxygenase (IDO) in human and inducible nitric oxide synthase (iNOS) in mouse. In the present study, we isolated MSCs from several mammalian species, each of a different genus, and investigated the involvement of IDO and iNOS during MSC-mediated immunosuppression. The characterization of MSCs from different species was by adherence to tissue culture plastic, morphology, specific marker expression, and differentiation potential. On the basis of the inducibility of IDO and iNOS by inflammatory cytokines in MSCs, the tested mammalian species fall into two distinct groups: IDO utilizers and iNOS utilizers. MSCs from monkey, pig, and human employ IDO to suppress immune responses, whereas MSCs from mouse, rat, rabbit, and hamster utilize iNOS. Interestingly, based on the limited number of species tested, the iNOS-utilizing species all belong to the phylogenetic clade, Glires. Although the evolutionary significance of this divergence is not known, we believe that this study provides critical guidance for choosing appropriate animal models for preclinical studies of MSCs. |
format | Online Article Text |
id | pubmed-3921585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-39215852014-03-01 Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species Su, J Chen, X Huang, Y Li, W Li, J Cao, K Cao, G Zhang, L Li, F Roberts, A I Kang, H Yu, P Ren, G Ji, W Wang, Y Shi, Y Cell Death Differ Original Paper Mammalian mesenchymal stem cells (MSCs) have been shown to be strongly immunosuppressive in both animal disease models and human clinical trials. We have reported that the key molecule mediating immunosuppression by MSCs is species dependent: indoleamine 2,3-dioxygenase (IDO) in human and inducible nitric oxide synthase (iNOS) in mouse. In the present study, we isolated MSCs from several mammalian species, each of a different genus, and investigated the involvement of IDO and iNOS during MSC-mediated immunosuppression. The characterization of MSCs from different species was by adherence to tissue culture plastic, morphology, specific marker expression, and differentiation potential. On the basis of the inducibility of IDO and iNOS by inflammatory cytokines in MSCs, the tested mammalian species fall into two distinct groups: IDO utilizers and iNOS utilizers. MSCs from monkey, pig, and human employ IDO to suppress immune responses, whereas MSCs from mouse, rat, rabbit, and hamster utilize iNOS. Interestingly, based on the limited number of species tested, the iNOS-utilizing species all belong to the phylogenetic clade, Glires. Although the evolutionary significance of this divergence is not known, we believe that this study provides critical guidance for choosing appropriate animal models for preclinical studies of MSCs. Nature Publishing Group 2014-03 2013-10-25 /pmc/articles/PMC3921585/ /pubmed/24162664 http://dx.doi.org/10.1038/cdd.2013.149 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Original Paper Su, J Chen, X Huang, Y Li, W Li, J Cao, K Cao, G Zhang, L Li, F Roberts, A I Kang, H Yu, P Ren, G Ji, W Wang, Y Shi, Y Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species |
title | Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species |
title_full | Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species |
title_fullStr | Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species |
title_full_unstemmed | Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species |
title_short | Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species |
title_sort | phylogenetic distinction of inos and ido function in mesenchymal stem cell-mediated immunosuppression in mammalian species |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921585/ https://www.ncbi.nlm.nih.gov/pubmed/24162664 http://dx.doi.org/10.1038/cdd.2013.149 |
work_keys_str_mv | AT suj phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT chenx phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT huangy phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT liw phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT lij phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT caok phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT caog phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT zhangl phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT lif phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT robertsai phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT kangh phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT yup phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT reng phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT jiw phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT wangy phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies AT shiy phylogeneticdistinctionofinosandidofunctioninmesenchymalstemcellmediatedimmunosuppressioninmammalianspecies |